⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 18, 2000JAMA

Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease

Parkinson Study Group

View at Publisher

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Parkinson Study Group (2000) studied this question.

synapsesocial.com/papers/69dba41174ec163421836161 https://doi.org/10.1001/jama.284.15.1931

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Sodium-Glucose Cotransporter 2 Inhibitor Use and Levels of Hemoglobin, Markers of Iron Metabolism, and ErythropoiesisJAMA · Sat,
2Increased Hemoglobin With Sodium-Glucose Transporter 2 Inhibitors—A Consistent Extra Benefit?JAMA · Sat,
3Global Heart Failure Burden Increased Between 1990 and 2023JAMA · Fri,
4ACC Releases Guidance for Managing Resistant HypertensionJAMA · Fri,
5Rituximab vs Azathioprine for Eosinophilic Granulomatosis With Polyangiitis Maintenance TherapyJAMA · Thu,

More from JAMA

A Technology Journalist Looks at AI and HealthThu,
Compounded GLP-1 Dispensing Patterns and Vitamin B 12 CoformulationThu,
Breast Cancer’s Transformation From Terminal to ManageableThu,
Visitors Must Check InThu,
Reforming Risk Adjustment in Medicare Advantage—A View From CongressThu,